Morrison & Foerster and ChinaBio® are pleased to join together to host a workshop for executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, and generate global intellectual property rights. The workshop will include sessions on: _Structuring a Global Life Science Company_ Relevant structuring considerations to: - Enhance financeability by U.S. and China investors - Maximize tax efficiency - Provide investor-friendly capital structure - Preserve flexibility and minimize regulatory approvals for a subsequent liquidity event _Building a Global Patent Portfolio_ Secure China, U.S., and international patents to effectively block your competition. - Significant changes in the U.S. due to the America Invents Act (AIA) - Recent U.S. court decisions on patentable subject matter - Adjusting China strategies in view of new U.S. law changes The State of China's Biotech Industry China’s life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, and other news. Speakers: - Chuck Comey, Partner, Morrison & Foerster LLP - Janet Xiao, Partner, Morrison & Foerster LLP - Jie Zhou, Partner, Morrison & Foerster LLP - Greg B. Scott, President & Founder, ChinaBio® none specified